MedCap AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 386.1 million compared to SEK 284.1 million a year ago. Revenue was SEK 390 million compared to SEK 286.3 million a year ago. Net income was SEK 46.8 million compared to SEK 21 million a year ago. Basic earnings per share from continuing operations was SEK 3.2 compared to SEK 1.4 a year ago. Diluted earnings per share from continuing operations was SEK 3.2 compared to SEK 1.4 a year ago.
For the six months, sales was SEK 766.3 million compared to SEK 546.9 million a year ago. Revenue was SEK 774 million compared to SEK 552 million a year ago. Net income was SEK 71.6 million compared to SEK 40.6 million a year ago. Basic earnings per share from continuing operations was SEK 4.8 compared to SEK 2.7 a year ago. Diluted earnings per share from continuing operations was SEK 4.8 compared to SEK 2.7 a year ago.